Genprex
$2.609876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.08 (-3.02%) Today
+$0.03 (+1.17%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Genprex and other stocks, options, ETFs, and crypto commission-free!
About GNPX
Genprex, Inc. Common Stock, also called Genprex, is a clinical stage gene therapy company, which engages in the development of novel proprietary technology platform for the treatment of cancer. Read More It develops the Oncoprex immunogene therapy which targets the non-small cell lung cancer and other solid tumors. The company was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.
Employees
7
Headquarters
Austin, Texas
Founded
2009
Market Cap
91.65M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.13M
High Today
$2.74
Low Today
$2.53
Open Price
$2.58
Volume
751.47K
52 Week High
$7.03
52 Week Low
$0.231